Investing.com - Biocept reported on Friday third quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Biocept announced earnings per share of $-0.310 on revenue of $10.61M. Analysts polled by Investing.com EPS of $-0.230 on revenue of $8.95M.
Biocept 's are down 53.92% and is trading at $0.800 , still down 81.80% from its 52 week high of $4.40 set on Wednesday, December 1, 2021.
Biocept follows other major Healthcare sector earnings this month
Biocept's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar